Press Releases

« Back to all press releases

Medical Research Leaders, Innovators and Investors Come to New York to Forge Partnerships, Speed Cures

WASHINGTON, DC--(Marketwired - Nov 5, 2014) - On Nov. 16-18, nearly 1,000 medical research leaders, investors and decision-makers will come to New York City for the 6th annual Partnering for Cures meeting. Convened by FasterCures, a Washington-based center of the Milken Institute, this unique conference brings together innovators from across all sectors of the medical research enterprise -- academic scientists, federal policymakers, biotechnology and pharmaceutical executives, life science investors, foundations and patients -- to forge the partnerships needed to speed the path of promising discoveries from lab to patient.

"There are so many positive changes underway that are driving us towards a more open, collaborative, patient-driven system," said Margaret Anderson, executive director of FasterCures. "But there is also a vast to-do list to accept this change and advance it. That's what Partnering for Cures is all about -- breaking down the barriers that stand in the way of medical progress and working together to reduce the time and cost of R&D."

Partnering for Cures combines the outcomes-oriented approach of investor conferences with the networking environment of industry partnering meetings. It helps attendees find solutions to some of the thorniest challenges in medical research. Topics include: 

  • Putting patients in patient-centeredness, not just in word but in deed
  • The future of U.S. research leadership
  • Redefining the impact of biomedical research investments
  • The price of innovation: Who defines 'value'?
  • The blurring boundary between university and marketplace
  • And many more 

Speakers include: 

  • Anna Barker, Professor and Director, Transformative Healthcare Networks; Co-Director, Complex Adaptive Systems Network, Arizona State University
  • ShaAvhrée Buckman-Garner, Director, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • Atul Butte, Chief of the Division of Systems Medicine and Associate Professor of Pediatrics, Medicine, and Computer Science, Stanford University
  • Francis Collins, Director, National Institutes of Health
  • Meryl Comer, President, Geoffrey Beene Foundation Alzheimer's Initiative; Founder, WomenAgainstAlzheimers
  • The Honorable Diana DeGette, Chief Deputy Whip, U.S. House of Representatives
  • Deborah Dunsire, President & CEO, FORUM Pharmaceuticals
  • Esther Dyson, Founder, HICCup
  • Ilan Ganot, Founder and CEO, Solid Ventures
  • Kathy Giusti, Founder and Executive Chairwoman, Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
  • Laurie Glimcher, Dean, Weill Cornell Medical College
  • Michel Goldman, Director, Innovative Medicines Initiative
  • Allan Jones, CEO, Allen Institute for Brain Science
  • Michael Kolodziej, National Medical Director, Oncology Solutions, Office of the Chief Medical Officer, Aetna
  • Craig Lipset, Head, Clinical Innovation, Worldwide Research & Development, Pfizer Inc.
  • Eric Minikel and Sonia Vallabh, Co-Directors, Prion Alliance
  • Richard Pops, Chairman and CEO, Alkermes
  • Katherine Priestley, Managing Partner, Park Vale Capital
  • Melinda Richter, Head, Janssen Labs, Johnson & Johnson
  • Benjamin Seet, Executive Director, Biomedical Research Council, A*STAR
  • The Honorable Fred Upton, Chairman, Committee on Energy and Commerce, U.S. House of Representatives
  • Pascale Witz, Executive Vice President, Global Divisions & Strategic Development, Sanofi
  • And many more. 

In a new addition to the Partnering for Cures agenda, top entrepreneurs will describe how their mobile/digital health technology applications will increase patient participation in biomedical R&D. Moderated by a panel of experts representing entrepreneurship, drug development, clinical care, and disease philanthropy, Entrepreneurs for Cures will position three innovators with transformative products before a cross-sector audience ready to change the R&D paradigm. 

Held at the Grand Hyatt New York, Partnering for Cures is open to the public and to registered media. For registration information, go to www.partneringforcures.org/registration. Members of the press may apply here to receive complimentary registration.

Complete information about Partnering for Cures, including a full program and a list of speakers confirmed to date, is available at www.partneringforcures.org.

About FasterCures
FasterCures, a center of the Milken Institute, is an action tank, determined to remove barriers to medical progress. We have only one goal: to save lives by speeding up and improving the medical research system. 
www.fastercures.org, @FasterCures